Inventor
JEFFREY VESSELS
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes20%
PatentTitleYear
12,565,504Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors202612,522,595Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors202612,421,224Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors202512,319,679Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors202512,275,728O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors202512,180,205O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors202411,459,324O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors202211,427,561IRAK4 inhibiting agents2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to BIOGEN MA INC (8)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOGEN MA INC | 8 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |